iRhythm Technologies

Senior Test Automation Engineer (SDET)

United States

Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Medical Device, Healthcare Technology, SoftwareIndustries

Requirements

Candidates should possess 8-10 years of experience in test automation and framework development, with expertise in an object-oriented programming language like Java or C#. Proficiency in testing tools such as TestNG, REST Assured, Selenium Web Driver, Playwright, Appium, and Postman is required, along with experience in Agile methodologies and workflow tools like Jira or Azure DevOps. Excellent communication skills, a passion for quality, and attention to detail are essential. Experience with medical devices is a plus.

Responsibilities

The Senior Test Automation Engineer will develop scalable test frameworks and design automated testing solutions for applications supporting the cardiac monitoring device lifecycle. Responsibilities include developing stable and reliable test automation, particularly for REST API-based services, and contributing to improvements that reduce manual effort. The role involves organizing and reporting on testing efforts using tools like Jira and Jama, partnering with stakeholders to communicate results, and supporting the medical device development lifecycle. Additionally, the engineer will mentor peers and drive engineering excellence in cloud-based SaaS platforms.

Skills

Test Automation
SDET
REST API
Test Frameworks
Continuous Integration
Jira
Jama
SaaS

iRhythm Technologies

Advanced cardiac monitoring solutions provider

About iRhythm Technologies

iRhythm Technologies focuses on cardiac monitoring solutions, with its main product being the Zio Patch, a wearable device that tracks heart rhythms for up to 14 days. This extended monitoring helps healthcare providers detect irregular heart rhythms that shorter monitoring might miss, making it especially useful for patients at risk. The company serves both patients and healthcare providers, generating revenue by selling the Zio Patch and offering data analysis services to interpret the collected heart data. iRhythm aims to improve patient outcomes and streamline healthcare workflows in the cardiac health sector.

San Francisco, CaliforniaHeadquarters
2006Year Founded
$102.8MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Holidays
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Mental Health Support
Hybrid Work Options
Pet Insurance

Risks

Increased competition from emerging cardiac monitoring technologies threatens market share.
FDA warning letter may lead to regulatory scrutiny and potential fines.
Shareholder investigation could result in legal challenges and financial liabilities.

Differentiation

Zio Patch offers up to 14 days of uninterrupted cardiac monitoring.
iRhythm's Zio Patch is the smallest and least conspicuous cardiac diagnostic device.
The company provides data analysis services for actionable insights from Zio Patch data.

Upsides

Wearable health tech market growth aligns with iRhythm's business model.
Telehealth expansion increases demand for remote monitoring solutions like Zio Patch.
AI integration enhances arrhythmia detection accuracy in iRhythm's Zio Patch.

Land your dream remote job 3x faster with AI